Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Other Accumulated Expenses (2016 - 2017)

Historic Other Accumulated Expenses for Wave Life Sciences (WVE) over the last 3 years, with Q4 2017 value amounting to $156000.0.

  • Wave Life Sciences' Other Accumulated Expenses fell 8354.43% to $156000.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $156000.0, marking a year-over-year decrease of 8354.43%. This contributed to the annual value of $156000.0 for FY2017, which is 8354.43% down from last year.
  • According to the latest figures from Q4 2017, Wave Life Sciences' Other Accumulated Expenses is $156000.0, which was down 8354.43% from $948000.0 recorded in Q4 2016.
  • Over the past 5 years, Wave Life Sciences' Other Accumulated Expenses peaked at $948000.0 during Q4 2016, and registered a low of $156000.0 during Q4 2017.
  • For the 3-year period, Wave Life Sciences' Other Accumulated Expenses averaged around $465750.0, with its median value being $379500.0 (2015).
  • Per our database at Business Quant, Wave Life Sciences' Other Accumulated Expenses surged by 16855.52% in 2016 and then crashed by 8354.43% in 2017.
  • Over the past 3 years, Wave Life Sciences' Other Accumulated Expenses (Quarter) stood at $353000.0 in 2015, then surged by 168.56% to $948000.0 in 2016, then tumbled by 83.54% to $156000.0 in 2017.
  • Its Other Accumulated Expenses stands at $156000.0 for Q4 2017, versus $948000.0 for Q4 2016 and $353000.0 for Q4 2015.